Logo
x

Search

Subscribe Now

Metastatic Cervical Cancer

PharmaShots Interview: Genmab's Jan van de Winkel Shares Insight on the Tivdak (tisotumab vedotin-tftv) for the Treatment of Recurrent or Metastatic Cervical Cancer

PharmaShots Interview: Genmab's Jan van de Winkel Shares Insight on the Tivdak (tisotumab vedotin-tftv) for the Treatment of Recur...

  • November 15, 2021
Lee's Pharma Socazolimab Receives NMPA's Breakthrough Therapy Designation for Treatment of Recurrent or Metastatic Cervical Cancer

Lee's Pharma Socazolimab Receives NMPA's Breakthrough Therapy Designation for Treatment of Recurrent or Metastatic Cervical Cancer

  • February 10, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.